|
Volumn 4, Issue 5, 2002, Pages 343-349
|
New targets for medical treatment of lipid disorders.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ANIMAL;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DRUG EFFECT;
FEMALE;
HUMAN;
HYPERLIPIDEMIA;
MALE;
MORTALITY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SURVIVAL;
TREATMENT OUTCOME;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
CORONARY DISEASE;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
MALE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0037956783
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-002-0071-x Document Type: Review |
Times cited : (11)
|
References (45)
|